🚨 New study alert! "Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score-matched analysis" just dropped! 📊🫀 See: ow.ly/xOq350VCpAZ #CardioTwitter #HeartFailure #HFrEF #QuadrupleTherapy

PVC localization on ECG. Premature ventricular complexes (PVCs) are early depolarizations originating from the ventricles, bypassing the His-Purkinje system. This powerful image illustrates PVCs from different anatomical origins➡️outflow tracts (RVOT/LVOT) and the tricuspid

Clinical staging to guide management of metabolic disorders and their sequelae: European Atherosclerosis Society statement European Society of Cardiology Journals 1️⃣ insulin resistance/pre-diabetes alone or overweight/dysfunctional adiposity + 1 one the following: liver steatosis, hypertension, or atherogenic dyslipidaemia

SGLT2 inhibitors vs GLP-1 receptor agonists: A nationwide study reveals that SGLT2 inhibitors reduce hospitalization for heart failure in diabetes patients with atrial fibrillation (AF) but show no benefit in non-AF patients. Both classes improve kidney outcomes, but major CV

The role of epicardial adipose tissue remodelling in #HFpEF Discover more in this must-read #CardiovascularResearch Review including mechanistic insights & novel therapeutic targets ow.ly/oEQP50VP9vg CVR Tomasz Guzik Glen Pyle | #WomensHeartHealth ❤️‍🩹🖇️ Mike Drozd Sarah Brown #HF #heartfailure

Empagliflozin in Patients with CKD Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from cardiovascular causes nejm.org/doi/full/10.10…

🔴 Tirzepatide as Compared with Semaglutide for the Treatment of Obesity A head-to-head trial finally answers: is tirzepatide more effective than semaglutide for obesity in non-diabetics? We@NEJM: the SURMOUNT-5 trial. #Obesity #CardioTwitter #GLP1 #Tirzepatide #Semaglutide

TOP TEN PAPERS EN DIABETES Y CARDIOMETABOLISMO 2024 🔴Surmount-OSA 🔴BPROAD 🔴Combinación GLP1 y SGLT2 en DBT 🔴FLOW subanálisis 🔴STEP-HFpEF 🔴SELECT-FLOW-STEP HFpEF Y STEP-HFpEF DM 🔴DBT gestacional y enf. CV 🔴DBT gestacional y epigenética academic.oup.com/eurheartj/adva…

Staring into the AβYSS: how many pills and for how long after myocardial infarction? academic.oup.com/eurheartj/arti…

. eurointervention.pcronline.com/article/one-mo…

Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model academic.oup.com/eurheartj/arti…

facebook.com/share/p/1YwJDh…

🔝 Artículo de revisión - Finerenona en la interfase cardiorrenal: más allá del riesgo residual ⚕️ Jorge Salamanca Viloria Jorge Salamanca Viloria 🔎 cardioteca.com/blog-finerenon…

🚨 Think you know NOAC dosing? 🧠 Quiz time: 1️⃣ Apixaban dose if age ≥80 & Cr ≥1.5? 2️⃣ When to use Edoxaban 30 mg? 3️⃣ Rivaroxaban DVT: how many days 15 mg BID? 4️⃣ Which NOACs need heparin first? 📘 Answers on p.131 of Tips and Tricks in Cardiology DM “Tips” to get your copy!

Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials In this participant-level pooled analysis of 4 large-scale HFpEF outcome trials, obesity and excess abdominal adiposity were highly

📢 Estudio ULTIMATE DAPT Antonio Ruiz Saavedra Diapositivas aquí⤵️ cardioteca.com/diapositivas-p…

✨Cardiac MRI: A Game Changer for Nonischemic Cardiomyopathies 🫀‼️ ✅ Accurate Diagnosis ✅ Better Risk Stratification ✅ Tailored Treatment Plans #WhyCMR #StateOfTheArt JACC Journals #JACCHF

A new echocardiographic algorithm provides accurate classification of left ventricular filling pressure, reducing indeterminate cases, particularly in patients with preserved ejection fraction. Sherif F Nagueh ahajournals.org/doi/full/10.11…

Rivaroxaban 🆚 Warfarina en trombo VI

🆕 ACC scientific statement on the Dx & management of #pericarditis addresses diagnostic & therapeutic advances in acute & recurrent pericarditis & their complications, employing a multimodality imaging-guided therapeutic approach. Get the details: jacc.org/doi/10.1016/j.… #JACC